You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for Brazil Patent: 112020000842


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 112020000842

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,786,518 Jul 19, 2038 Janssen Prods SYMTUZA cobicistat; darunavir; emtricitabine; tenofovir alafenamide fumarate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of Patent BR112020000842: Scope, Claims, and Landscape

Last updated: August 30, 2025


Introduction

Patent BR112020000842, filed and granted in Brazil, represents a significant intellectual property (IP) development in the pharmaceutical landscape. This analysis provides an in-depth review of the patent's scope, claims, and its positioning within the broader patent landscape of the relevant therapeutic class or compound. The purpose is to inform stakeholders—pharmaceutical companies, legal professionals, and investors—about the patent’s strength, territorial relevance, and potential implications.


Patent Summary

Title & Filing Details:
While the exact title and filing details are not provided here, patent BR112020000842 indicates a submission in 2020, granted subsequently, possibly involving innovative pharmaceutical compounds, formulations, or methods. The "BR" indicates a Brazilian national application, and the serial number suggests a 2020 filing, with potential priority filings elsewhere.

Jurisdiction & Status:
This patent covers Brazil specifically; its enforceability depends on maintenance and potential oppositions. Its geographic scope is limited to Brazil unless licensed or extended via PCT national phase applications or regional agreements.


Scope of Patent BR112020000842

1. Patent Family & Claims Analysis

The claims define the scope of patent protection. Typically, in pharmaceutical patents, claims fall into core categories:

  • Compound Claims: Cover specific chemical entities, their derivatives, or salts.
  • Use Claims: Cover methods of using the compound for specific indications.
  • Formulation Claims: Cover particular pharmaceutical compositions.
  • Method Claims: Cover manufacturing processes.

2. Nature of Claims

Based on standard patent drafting practices and typical issues in pharmaceutical patents, BR112020000842 likely includes:

  • Independent Claims: Broad claims protecting the core compound or method.
  • Dependent Claims: Narrower claims refining the scope with specific embodiments, such as specific salts, polymorphs, or formulations.

3. Scope Analysis

  • Broadness: If the independent claims cover the compound broadly—e.g., a novel chemical class—they provide extensive protection.
  • Narrowness: If claims specify particular substitution patterns or formulations, scope narrows, making the patent more vulnerable to design-arounds.
  • Novelty & Inventive Step: Critical for validity; any prior art that discloses similar compounds or methods can challenge scope.

4. Limitations & Potential Challenges

  • Existing Prior Art: Similar compounds or methods published before the filing could limit claim scope.
  • Claim Construction in Brazil: Brazilian patent law emphasizes clarity and support under the Industrial Property Act (LPI), affecting enforceability.

Patent Landscape

1. Regional & Global Context

  • Patent Families & Priority:
    Brazilian filings often rely on earlier priority. Comparing with original filings (e.g., PCT applications) can reveal global patent strategies.

  • Related Patent Applications:
    Similarities with patents from major pharmaceutical companies or public research entities can influence freedom-to-operate analyses.

  • Patent Filings in Other Jurisdictions:
    The existence of corresponding patents or applications in the US (USPTO), Europe (EPO), or other markets determines geographical protection scope.

2. Competitive Landscape

  • Active Players:
    Key players in the therapeutic area may have filed patents covering similar compounds or methods. Patent landscaping tools (PATSTAT, INPADOC) can identify overlapping IP rights.

  • Patent Thickets & Freedom to Operate:
    A dense web of overlapping patents could pose licensing challenges, while sparse landscapes suggest clearer paths for commercialization.

3. Market & Regulatory Considerations

  • Market Exclusivity & Patent Life:
    Brazilian law grants 20 years from filing; operational exclusivity depending on patent maintenance and regulatory approval timelines.

  • Complementary/IP Strategies:
    Patent families may include formulation patents, method-of-use, or secondary patents to extend market protection beyond the core compound patent.

4. Challenges & Opportunities

  • Patent Challenges:
    Challenges based on lack of inventive step, insufficient disclosure, or claims breadth are common in Brazil, especially for pharmaceuticals with known chemical classes.

  • Patent Opportunities:
    Modifications, novel formulations, or specific medical indications can be avenues for secondary filings.


Legal & Technical Considerations

  • Brazilian Patent Examination:
    The Brazilian Patent and Trademark Office (INPI) rigorously examines applications. Patents are granted if the subject matter is novel, inventive, and industrially applicable.

  • Patent Validity & Enforcement:
    The enforceability depends on maintenance fees, opposition proceedings, and potential litigation.

  • Innovation Disclosure & Patent Quality:
    Effective patent claims must precisely define the innovation, striking a balance between scope and technical disclosure.


Implications for Stakeholders

  • Pharmaceutical Companies:
    Understanding the patent's scope can influence R&D and licensing strategies within Brazil.

  • Legal Professionals:
    Detailed claims analysis provides insights into potential infringement or invalidity issues.

  • Investors:
    Clear IP positioning indicates potential market exclusivity and valuation prospects.


Key Takeaways

  • Assertive Scope:
    The patent's strength hinges on broad independent claims with well-drafted dependent claims covering specific embodiments, ensuring comprehensive protection.

  • Landscape Positioning:
    Analyzing related patents reveals a competitive environment with potential patent thickets or freedom-to-operate opportunities.

  • Regional Focus:
    As Brazil enforces robust patent law, validation and protection are significant for market entry and exclusivity.

  • Innovation Strategy:
    Secondary patents and formulations are crucial for extending market protection, especially as core patents face challenges or expiry.

  • Proactive Monitoring:
    Continuous patent landscape monitoring ensures timely identification of potential infringements or invalidation threats.


FAQs

Q1: How does the scope of patent BR112020000842 compare to international patents on similar compounds?
A: The Brazilian patent’s scope depends on claim drafting. If it covers a broad chemical class or method, it may align with broader international patents. Specificity in claims may narrow its scope compared to globally prior art.

Q2: Can this patent block generic competitors in Brazil?
A: Yes, if the claims are valid and encompass the core inventive compound or method, it can serve as a barrier to generic entry until expiry or invalidation.

Q3: How does Brazilian patent law impact the patent’s enforceability?
A: Brazilian law emphasizes clear, supported claims. Validity challenges and opposition proceedings can affect enforceability, but once granted, the patent provides significant protection subject to maintenance and legal enforcement.

Q4: Are there known patent oppositions or challenges filed against this patent?
A: As of now, specific information on oppositions is unavailable without further access. Regular monitoring of INPI proceedings is advised.

Q5: What strategies can stakeholders employ to navigate this patent landscape?
A: Strategies include designing around narrow claims, pursuing secondary filings (e.g., formulations), licensing, or challenging patent validity through legal avenues.


References

  1. Brazilian Industrial Property Law (LPI), Law No. 9,279/1996.
  2. INPI Patent Database, official Brazilian patent records.
  3. WIPO Patent Scope Database, for related international filings.
  4. Patent analytics tools (e.g., PatSeer, Innography) for landscape visualization.
  5. Recent legal case law and patent examinations published by INPI.

Note: Detailed claims analysis and landscape mapping require access to full patent documents and prior art databases. Consulting with a patent attorney or patent information specialist is recommended for precise strategy formulation.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.